Response to letter entitled: Re: Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? An international multicenter analysis

Bergamini, A; Sarwar, N; Ferrandina, G; Scarfone, G; Short, D; Aguiar, X; Camnasio, C; Kaur, B; Savage, PM; Cormio, G; Lim, A; Pignata, S; Mangili, G; Seckl, MJ

Bergamini, A (corresponding author), Univ Vita Salute San Raffaele, Dept Obstet & Gynecol, Via Olgettina 60, Milan, Italy.; Seckl, MJ (corresponding author), CXH Imperial Coll London, IRCCS San Raffaele Hosp, Charing Cross Hosp, Gestat Trophoblast Dis, London W68RF, England.; Seckl, MJ (corresponding author), CXH Imperial Coll London, Malignant Germ Cell Tumor Serv, Charing Cross Hosp, London W68RF, England.

EUROPEAN JOURNAL OF CANCER, 2021; 152 (): 257